Sirtuin 3 promotes osteogenic differentiation of bone marrow mesenchymal stem cells by regulating macrophage polarization under high glucose Authors: Linni Lin, Yijie Ren, Xia Wang, Hengxing Liang, Qianqian Yao Published: 2025 ABSTRACT AbstractUnder high glucose conditions, the bone repair process is impaired, in which macrophage polarization plays a critical role. This study aims to investigate the role of the Sirtuin 3/Forkhead box O3a (SIRT3/FoxO3a) pathway in regulating macrophage polarization under hyperglycemic conditions and its impact on the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). By establishing an in vitro high-glucose model in RAW264.7 macrophages, we found that high glucose suppressed the SIRT3/FoxO3a pathway, leading to increased reactive oxygen species (ROS) levels, reduced autophagy activity, and promoted polarization of macrophages toward the M1 phenotype. In contrast, SIRT3 overexpression reversed these effects, promoting macrophage polarization toward the M2 phenotype. When BMSCs were co-cultured with conditioned medium from macrophages, the medium derived from SIRT3-overexpressing macrophages significantly enhanced the proliferation, migration, and osteogenic differentiation capacity of BMSCs. The findings suggest that targeting the SIRT3/FoxO3a pathway may represent a promising novel strategy for improving bone healing in diabetic patients.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-025-33483-9.Keywords: Macrophage polarization, Mesenchymal stem cells, Osteogenic differentiation, Oxidative stress, AutophagySubject terms: Cell biology, Diseases, Molecular biology, Stem cells Introduction Diabetes mellitus (DM) is one of the three major chronic diseases globally, and the number of diabetic patients worldwide is projected to reach 783 million by 20451. DM is a critical risk factor for dental implant therapy2. Clinical studies have revealed that the incidence of peri-implantitis is significantly higher in diabetic patients compared to non-diabetics3. Chronic hyperglycemia can negatively affect osseointegration, manifesting as disorder in bone tissue arrangement around the implant, a lack of new bone tissue, poor maturity and continuity, poor trabecular bone parameters, and lower expression of the related growth factors4. These pathological alterations result from hyperglycemic oxidative stress that compromises the local microenvironment and ultimately undermines bone regeneration. Current studies emphasize the pivotal role of the immune microenvironment in osteogenesis5. As primary effector cells in the inflammatory cascade, macrophages emerge as a central component of innate immunity that orchestrates bone regeneration in concert with stem cells6. Macrophages exhibit dual roles during bone healing. In the early stages, macrophages are activated to the M1 phenotype, which participates in the phagocytosis of pathogens and cell fragments. While in the later stages of fracture healing, macrophages switch from M1 to M2 phenotype, promoting anti-inflammation and angiogenesis, and enhancing osteogenesis mediated by bone marrow mesenchymal stem cells (BMSCs)7. Notably, DM is a chronic inflammatory disorder that triggers excessive M1 activation in macrophages, impairing the transition from pro-inflammatory to anti-inflammatory states and compromising bone healing8,9. Therefore, strategies to modulate macrophage polarization represent a promising therapeutic avenue for improving diabetic bone integration. Sirtuin 3 (SIRT3), a predominantly mitochondrial-localized and highly conserved nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase, plays a critical role in mitochondrial homeostasis, oxidative stress, and immune cell function10. SIRT3 can directly target and deacetylate the transcription factor Forkhead box O3 (FoxO3a) to control the different cellular responses to oxidative stress11. It is reported that macrophages from SIRT3 knockout mice exhibit altered redox homeostasis and a pro-inflammatory phenotype12. A recent study showed that SIRT3 deacetylates and activates FoxO3a to promote mitophagy and autophagy, thus promoting stem cell osteogenic differentiation13. Notably, SIRT3 expression in DM is associated with enhanced mitochondrial oxidative stress and delayed fracture healing14. While the roles of the SIRT3/FoxO3a axis in mitigating oxidative stress, promoting autophagy, and supporting osteogenesis have been established in various cell types13,15, its specific regulatory function in macrophage polarization and function, particularly under diabetic conditions, has yet to be fully elucidated. Given that SIRT3 expression is decreased in diabetes and is associated with heightened oxidative stress and delayed fracture healing, we hypothesized that SIRT3 in macrophages serves as a critical modulator of the M1/M2 balance under high glucose, thereby influencing the osteogenic capacity of BMSCs. In this study, we aim to establish an in vitro hyperglycemic cell model to comprehensively investigate the regulatory effects of SIRT3 on macrophage polarization and its impact on BMSCs osteogenic differentiation under hyperglycemic conditions. Results HG promotes M1 polarization of RAW264.7 cells As shown in Fig. 1, HG exposure significantly upregulated the M1 markers iNOS and TNF-α while downregulating the M2 markers CD206 and Arg-1 in RAW264.7 cells at both mRNA and protein levels. These results demonstrate that HG promotes a phenotypic shift from M2 to M1 polarization. High glucose promotes M1 polarization of RAW264.7 cells. (A) RT-qPCR analysis of mRNA expression of M1 markers (iNOS, TNF-α) and M2 markers (CD206, Arg-1) in cells treated with 30 mM D-glucose for 48 h. (B) Western blotting analysis of iNOS, TNF-α, CD206, and Arg-1 protein levels. Data: mean ± SD (n = 3). *P < 0.05, ** P < 0.01, *** P < 0.001 vs. 5 mM group. HG suppresses the SIRT3/FoxO3 signaling pathway in RAW264.7 cells To investigate the effects of HG on the SIRT3/FoxO3a pathway in macrophages, changes in SIRT3 and FoxO3a expression were systematically assessed using qRT-PCR, Western blotting, and subcellular localization analysis. Results showed that HG significantly downregulated both mRNA and protein levels of SIRT3 and FoxO3a in RAW264.7 cells compared to the NG group (Fig. 2A-B). Immunofluorescence co-localization analysis revealed a marked reduction in the co-localization coefficient of SIRT3 and FoxO3a in the HG group (P < 0.001), indicating impaired protein interaction (Fig. 2C). Nuclear-cytosolic fractionation showed a significant decrease in nuclear FoxO3a levels in the HG group, while cytosolic FoxO3a showed an upward trend without statistical significance (Fig. 2D). The finding was corroborated by immunofluorescence analysis, which showed reduced nuclear localization of FoxO3a in the HG group (Fig. 2E). Collectively, hyperglycemia suppresses the transcriptional and protein expression of the SIRT3/FoxO3a pathway, disrupts SIRT3-FoxO3a interaction, and impedes FoxO3a nuclear translocation. High glucose suppresses the SIRT3/FoxO3a pathway in RAW264.7 cells. (A) The mRNA expression of SIRT3 and FoxO3a was measured by RT‑qPCR. (B) The protein expression of SIRT3 and FoxO3a was analyzed by western blotting. (C) Immunofluorescence images showing co‑localization of SIRT3 (red) and FoxO3a (green). Nuclei were stained with DAPI (blue). The extent of co‑localization was quantified using Pearson’s correlation coefficient. (D) Subcellular fractionation analysis of FoxO3a distribution in nuclear and cytoplasmic compartments. (E) Quantitative analysis of FoxO3a nuclear translocation by immunofluorescence. Data: mean ± SD (n = 3). *P < 0.05, ** P < 0.01, *** P < 0.001 vs. 5 mM group. HG exacerbates oxidative stress and inhibits autophagy in RAW264.7 cells After 48 h of high-glucose intervention, DCFH-DA fluorescent probe detection revealed that intracellular ROS levels in the HG group were significantly higher than those in the NG group (Fig. 3A), indicating that a high-glucose microenvironment can induce oxidative damage in macrophages. Further analysis of autophagy-related proteins by western blotting showed that in the HG group, the autophagy substrate SQSTM1 protein accumulated significantly, while the LC3B-II/LC3B-I ratio decreased markedly compared to the NG group. Additionally, the LC3B-II/β-actin protein expression level was significantly reduced (Fig. 3B), demonstrating that the high-glucose environment significantly inhibits autophagy in macrophages. High glucose exacerbates oxidative stress and inhibits autophagy in RAW264.7 cells. (A) Intracellular ROS levels were evaluated by fluorescent staining and quantification of fluorescence intensity. (B) Expression levels of autophagy markers SQSTM1 and LC3B were analyzed by Western blotting and quantified. Data: mean ± SD (n = 3). PC: Positive Control, *P < 0.05, ** P < 0.01, *** P < 0.001 vs. 5 mM group. SIRT3 overexpression reverses HG-induced M1 polarization RAW264.7 cells were transfected with the OE-SIRT3 plasmid or the corresponding control Vector. Fluorescence microscopy confirmed a transfection efficiency of > 70%. The OE-SIRT3 group exhibited significantly elevated SIRT3 mRNA and protein levels compared to the non-transfected control (NC) and Vector groups (Fig. 4A-C), confirming successful SIRT3 overexpression. SIRT3 overexpression reverses high-glucose-induced M1 polarization and activates the SIRT3/FoxO3a signaling pathway. (A) Fluorescence image of RAW264.7 cells showing zsGreen-positive cells after transfection with the SIRT3 overexpression plasmid. (B-C) Validation of SIRT3 overexpression efficiency: (B) mRNA level by RT-qPCR; (C) protein level by western blotting. (D-E) Effect of SIRT3 overexpression on M1/M2 polarization markers under high-glucose conditions: (D) mRNA expression of iNOS, TNF-α, CD206, and Arg-1 (RT-qPCR); (E) protein expression of iNOS, TNF-α, CD206, and Arg-1 (western blotting). (F-G) Effect of SIRT3 overexpression on the SIRT3/FoxO3 signaling pathway: (F) mRNA expression of SIRT3 and FoxO3a (RT-qPCR); (G) protein expression of SIRT3 and FoxO3a (western blotting). (H) Analysis of FoxO3a subcellular distribution (nuclear and cytoplasmic fractionation) following SIRT3 overexpression. NC: Natural Control (Controls without transfection). Data: mean ± SD (n = 3). *P < 0.05, ** P < 0.01, *** P < 0.001 vs. Vector group. As shown in Fig. 4D-E, the OE-SIRT3 group exhibited a significant downregulation of M1 markers (iNOS, TNF-α) and a concurrent upregulation of the M2 marker Arg-1 at both transcriptional and protein levels. The mRNA expression of another M2 marker, CD206, was also significantly increased (P < 0.01), although its protein level showed only a non-significant upward trend. These results indicate that SIRT3 overexpression can reverse high glucose-induced M1 polarization and promote a shift toward the M2 phenotype. The OE-SIRT3 group had significantly increased levels of FoxO3a mRNA and protein (Fig. 4F-G). Nuclear-cytosolic fractionation showed enhanced FoxO3a nuclear translocation, with significantly increased cytosolic FoxO3a levels and decreased cytoplasmic FoxO3a levels in the OE-SIRT3 group compared to the vector group (Fig. 4H). These findings indicate that SIRT3 overexpression under high-glucose conditions activates the SIRT3/FoxO3a pathway and promotes the nuclear translocation of FoxO3a. SIRT3 overexpression reverses oxidative stress and activates autophagy under HG To evaluate the effect of SIRT3 overexpression on oxidative stress in RAW264.7 under HG conditions, intracellular ROS levels were measured using the DCFH-DA fluorescent probe. The results showed that ROS levels were significantly higher in the HG group than in the NG group, while no significant difference was observed between the Vector and HG groups. In contrast, ROS levels in the OE-SIRT3 group were significantly lower than those in the HG and Vector groups, indicating that SIRT3 overexpression effectively alleviates high-glucose-induced oxidative damage (Fig. 5A). SIRT3 overexpression reverses oxidative stress and activates autophagy under high-glucose conditions. (A) Intracellular ROS levels were evaluated by fluorescent staining and quantification of fluorescence intensity. (B) Expression levels of autophagy markers SQSTM1 and LC3B were analyzed by Western blotting and quantified. Data: mean ± SD (n = 3). *P < 0.05, ** P < 0.01, *** P < 0.001 vs. Vector group. Western blotting analysis further revealed that, compared to the Vector group, the OE-SIRT3 group exhibited decreased protein levels of the autophagy substrate SQSTM1, along with significantly increased LC3B-II/LC3B-I ratio and LC3B-II/β-actin expression (Fig. 5B). These results suggest that SIRT3 overexpression activates autophagy in macrophages under high-glucose conditions. Macrophage-conditioned media (MCM) from SIRT3‑overexpressing macrophages promotes migration, proliferation, and osteogenic differentiation of BMSCs To investigate the effects of MCM on the proliferation and migration of BMSCs, scratch assays and CCK-8 assays were performed. BMSCs cultured in OE-SIRT3 MCM exhibited slightly increased migration on day 1 and significantly enhanced migration on day 3 compared to those in Vector MCM (Fig. 6A-B). CCK-8 results showed superior proliferation of BMSCs in the OE-SIRT3 MCM, with significantly higher cell viability on days 3 and 5 (Fig. 6C), indicating that OE-SIRT3 macrophages create a pro-regenerative microenvironment via paracrine signaling. Conditioned medium from SIRT3‑overexpressing macrophages promotes migration, proliferation and osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs). (A, B) Cell scratch (wound healing) assay evaluating the migratory capacity of BMSCs. (C) CCK-8 assay assessing the proliferative activity of BMSCs. (D) Alkaline phosphatase (ALP) staining and activity assay measuring early osteogenic differentiation of BMSCs after 7 days of culture. (E) Alizarin Red S staining and cetylpyridinium chloride (CPC)-based quantification of mineralised nodule formation in BMSCs after 28 days of culture. (F) RT-qPCR analysis of BMP-2 mRNA expression in RAW264.7 cells transfected with the indicated vectors. (G) RT-qPCR analysis of mRNA expression levels of osteogenic markers (ALP, COL1A1, OPG) in BMSCs after 28 days of culture with conditioned medium. Data: mean ± SD (n = 3). *P < 0.05, ** P < 0.01, *** P < 0.001 vs. Vector group. To further evaluate the osteogenic effects, ALP activity and mineralized nodule formation were analyzed. After 7 days of osteogenic induction, BMSCs in OE-SIRT3 MCM displayed intensified ALP staining and significantly higher ALP activity than those in Vector MCM (Fig. 6D). Following 28 days of induction, Alizarin Red staining and quantitative analysis revealed significantly increased mineralized nodule formation of BMSCs in OE-SIRT3 MCM (Fig. 6E). At the molecular level, RT‑qPCR analysis showed that SIRT3 overexpression in RAW264.7 cells significantly upregulated the mRNA expression of the key osteogenic mediator BMP‑2 (Fig. 6F). Accordingly, the mRNA expressions of the osteogenic markers ALP, collagen type I alpha 1 chain (COL1A1), and osteoprotegerin (OPG) were significantly upregulated in BMSCs of the OE-SIRT3 MCM group (Fig. 6G). These findings collectively indicate that SIRT3 modulates macrophage function to enhance the osteogenic differentiation of BMSCs. Discussions This study reveals that HG significantly inhibits the SIRT3/FoxO3a signaling pathway, leading to increased intracellular ROS levels that intensify oxidative stress and suppress autophagy. Consequently, macrophages polarize toward the pro-inflammatory M1 phenotype. SIRT3 overexpression effectively reverses this polarization, promoting the anti-inflammatory M2 phenotype. Further research confirms that the extracellular matrix secreted by SIRT3-overexpressing macrophages upregulates osteogenesis-related gene expression in BMSCs, enhancing their osteogenic differentiation. These findings offer new theoretical insights for improving implant osseointegration in diabetic patients. As a chronic metabolic disorder characterized by a systemic pro-inflammatory state, DM can impair both angiogenesis and bone regeneration processes16. Substantial evidence identifies hyperglycemia as a risk factor for early implant failure and peri-implant inflammatory complications17. Our previously published studies have also demonstrated reduced bone mass and inhibited bone formation around implants in diabetic mice18. Since the pioneering concept of ‘osteoinmunology’ was introduced by Takayanagi et al. in 2000, numerous investigations have revealed that a favorable immune microenvironment is crucial for successful osseointegration19,20. Among various immune cells, macrophages are the first to interact with implant surfaces and serve as pivotal regulators connecting bone metabolism with immune responses, playing vital roles in maintaining homeostasis and tissue repair21. Accumulating evidence indicates that high glucose-induced accumulation of advanced glycation end products (AGEs) and oxidative stress can trigger excessive M1 macrophage activation, and this sustained pro-inflammatory state can impair the bone healing process22. Our studies using high glucose to simulate diabetic conditions demonstrate that HG promotes macrophage polarization toward the M1 phenotype and stimulates secretion of pro-inflammatory factors, consistent with previous findings23. However, the underlying mechanisms connecting macrophage polarization and impaired osteogenesis in the diabetic microenvironment require further elucidation. SIRT3, a mitochondrial-localized NAD⁺-dependent deacetylase, is a key regulator of cellular metabolism, stress response, and mitophagy24. Its downregulation in diabetes is linked to mitochondrial dysfunction, oxidative stress, and impaired bone healing14. High glucose conditions promote macrophage metabolism from oxidative phosphorylation to glycolysis, thereby increasing ROS and promoting a pro-inflammatory state25. Consistent with this, Yuan et al. demonstrated that HG-induced mitochondrial dysfunction and blocked autophagy drive M1 polarization26, while Barcena et al. showed that SIRT3 upregulation alleviates inflammation by reducing SOD2 acetylation and mitochondrial ROS27. Therefore, we hypothesized that restoring SIRT3 expression would mitigate oxidative stress, reactivate autophagy, and reprogram macrophages from an M1 to an M2 phenotype under HG conditions. Our results indicate that high glucose downregulated SIRT3 expression in macrophages, concomitant with M1 marker upregulation, aggravated oxidative stress, and suppressed autophagy, consistent with previous reports28. Conversely, SIRT3 overexpression effectively reversed the macrophage phenotypic shift, while reducing ROS and restoring autophagy. These findings indicate that SIRT3 promotes the shift from M1 to M2 polarization in macrophages under hyperglycemic conditions by reducing oxidative stress and activating autophagy. As a deacetylase, SIRT3 primarily maintains cellular homeostasis by regulating protein acetylation levels29. The transcription factor FoxO3a is a key downstream target of SIRT3, extensively involved in critical processes like oxidative stress, DNA damage repair, and autophagy30. FoxO3a activity is regulated by post-translational modifications, and its dynamic nucleo-cytoplasmic shuttling directly determines target gene transcription efficiency. In the cytoplasm, FoxO3a is often bound to 14–3-3 proteins or phosphorylated by kinases like AKT, rendering it inactive31. Upon nuclear translocation and accumulation, FoxO3a recognizes Forkhead consensus sequences in the promoter regions of target genes, recruits transcriptional co-activators to form functional complexes, and drives the transcription of antioxidants, cell cycle inhibitors, etc.32 Notably, nuclear FoxO3a integrates diverse extracellular signals to regulate cellular homeostasis by dynamically modulating downstream gene expression profiles. Studies confirm that the SIRT3/FoxO3a axis reduces intracellular ROS by activating antioxidants like SOD2, a mechanism implicated in diabetic chronic inflammation and neurodegenerative diseases33. Our study found that HG reduces FoxO3a expression in macrophages. Immunofluorescence co-localization showed reduced SIRT3/FoxO3a interaction, and subcellular localization analysis indicated that HG impedes FoxO3a nuclear translocation. SIRT3 overexpression reversed this process. This aligns with Hu et al., who found that apelin-13 in diabetic mice restored hippocampal SIRT3, thereby promoting FoxO3a deacetylation and nuclear translocation, while the benefits were abolished by SIRT3 knockdown34. Yang et al. found SIRT3 downregulation inhibited the FoxO3a/PINK1/PRKN cascade, consequently damaging mitochondrial autophagy35. The latest research confirms that SIRT3-mediated FoxO3a deacetylation promotes its nuclear translocation and binding to the PRKN promoter, thereby activating mitophagy to drive osteogenic differentiation in MC3T3 cells15. Thus, FoxO3a serves as a central integrator downstream of SIRT3, coordinating critical processes such as oxidative stress, autophagy, and macrophage polarization. Following implant placement, the recruitment and osteogenic differentiation of BMSCs are critical for osseointegration36. Recent research underscores that macrophage-MSC crosstalk within the immune microenvironment is pivotal to bone formation, prompting strategies to enhance BMSCs osteogenesis by modulating macrophage polarization37. In the bone microenvironment, macrophages can polarize into pro-inflammatory M1 or anti-inflammatory M2 phenotypes. Imbalanced polarization and excessive M1 activation secrete pro-inflammatory factors (TNF-α, IL-6, IL-1) that promote osteoclast differentiation and inhibit BMSCs osteogenesis38. Conversely, M2 macrophages support bone regeneration by secreting osteoinductive factors (VEGF, TGF-β, IL-10)39,40. This study confirms that SIRT3 overexpression in macrophages significantly upregulates the expression of the key osteogenic factor BMP-2. As a member of the TGF-β superfamily, BMP-2 has been demonstrated by multiple studies to effectively promote the proliferation and osteogenic differentiation of mesenchymal stem cells41,42. Consistent with this established function, our Scratch assay and CCK-8 analysis demonstrate that conditioned medium from SIRT3-overexpressing macrophages also enhances the migration and proliferation of BMSCs., which aligns with reports by Zhang et al. on the pro-migratory effects of factors derived from M2 macrophages43. Furthermore, our co-culture experiments provide direct evidence that this macrophage-derived conditioned medium significantly boosts the osteogenic differentiation capacity of BMSCs. Notably, Zhang et al. also proposed a complementary mechanism whereby exosomes from M2 macrophages promote osteogenesis via activation of the Hedgehog signaling pathway44. In summary, SIRT3 may shape an immune microenvironment conducive to the osteogenic differentiation, migration, and proliferation of BMSCs by guiding macrophages toward M2 polarization and upregulating effector factors such as BMP-2. Nevertheless, the complete signaling network and the roles of other potential mediators require further in-depth investigation in future studies. This study elucidates how macrophages regulate the M1/M2 polarization balance through the SIRT3/FoxO3a signaling axis under hyperglycemic conditions, thereby promoting the osteogenic differentiation of BMSCs. These findings suggest that this pathway could represent a potential therapeutic target for enhancing bone healing in diabetes. However, this study has certain limitations. Firstly, while the research suggests SIRT3 may regulate macrophage M2 polarization via the FoxO3a signaling pathway and autophagy activation, the mechanism remains insufficiently validated. Specifically, FoxO3a knockout experiments were not conducted to confirm its specific role in mediating SIRT3 regulation of M2 polarization, reactive oxygen species metabolism, and autophagy. Furthermore, the necessity of autophagy restoration has not been validated through intervention with autophagy modulators. The underlying causal relationships require subsequent verification. Secondly, macrophage cell lines (RAW264.7) and BMSCs derived from juvenile non-diabetic mice cannot fully replicate the pathological microenvironment of adult diabetic patients, and the indirect co-culture system does not account for direct cell–cell interactions. In future in vitro studies, primary macrophages and BMSCs from adult diabetic animals will be subjected to direct co‑culture. For in vivo validation, a macrophage‑specific conditional SIRT3 knockout mouse model can be employed to establish a diabetic dental implantation model, thereby elucidating the mechanism by which SIRT3 regulates osseointegration under diabetic conditions. Methods Cell culture The murine macrophage cell line RAW264.7 (Shanghai Zhong Qiao Xin Zhou Biotechnology Co., Ltd, China) was grown in low-glucose (1.0 g/L) Dulbecco’s Modified Eagle’s Medium (DMEM; Gibco, USA), supplemented with 10% fetal bovine serum (FBS; Gibco, USA) and 100 U/ml penicillin–streptomycin (Gibco, USA) at 37 °C under 5% CO₂. Cells were passaged at 1:2 to 1:3 upon reaching 70–80% confluence. In the experiment, RAW264.7 cells were divided into normal glucose (NG, 5 mM) and high glucose (HG, 30 mM) groups and cultured under corresponding conditions for 48 h. The detailed protocol for establishing this in vitro hyperglycemic model is provided in Appendix 1 (Figure S1-2). Cell transfection The SIRT3 overexpression (OE-SIRT3) plasmid (GV657-SIRT3-3flag-zsGreen) and corresponding control vector were synthesized by GeneChem (Shanghai, China). RAW264.7 cells were inoculated on 6-well plates at a density of 1 × 10⁶ cells/well. Plasmid transfection using Lipo8000 (Beyotime, Shanghai, China) was performed according to the manufacturer’s instructions. Transfection efficiency was evaluated at 72 h by quantifying zsGreen-positive cells under fluorescence microscopy. Subsequently, the Vector group and OE-SIRT3 group MCM were collected for subsequent experiments. Quantitative real-time polymerase chain reaction (qRT-PCR) Total RNA was extracted using RNAiso Plus (Takara, Japan), and cDNA was reverse‐transcribed using HiScript® III All-in-one RT SuperMix Perfect for PCR (Vazyme, China), followed by RT-qPCR using ChamQ Universal SYBR qPCR Master Mix (Vazyme, China). The primer sequences used for performing RT‐qPCR are listed in Table 1. The relative mRNA expression levels were normalized using β-actin as an internal reference and calculated using the standard 2−ΔΔCt method. Table 1 The primer sequences used in the study.Gene nameForward sequencesReverse sequencesCD206ATCAATGCCACTGCCATGCCTACAGCTTGCCGTGCGTCTTGCArg-1AGACAGCAGAGGAGGTGAAGAGTACGGTAGTCAGTCCCTGGCTTATGGTiNOSACTCAGCCAAGCCCTCACCTACTCCAATCTCTGCCTATCCGTCTCGTNF-αTCTTCTCATTCCTGCTTGTGGGGTCTGGGCCATAGAACTGASIRT3GCTGCTTCTGCGGCTCTTATACACCAAAGGTCCCGTGGGCTTCAACFoxO3aCCGTGAGCAAGCCGTGTACTGTATCCAGCAGGTCGTCCATGAGGBMP-2GGGACCCGCTGTCTTCTAGTTCAACTCAAATTCGCTGAGGACALPCCGATGGCACACCTGCTTCACCAGGCACAGTGGTCAAGGTTGGCOL1A1GCATGGCCAAGAAGACATCCCCTCGGGTTTCCACGTCTCOPGAGCCACGCAAAAGTGTGGAATCCTCTCTACACTCTCGGCAβ-actinGGCTGTATTCCCCTCCATCGCCAGTTGGTAACAATGCCATGTNotes: CD206, Cluster of Differentiation 206; Arg-1, Arginase-1; iNOS, Inducible Nitric Oxide Synthase; TNF-α, Tumor Necrosis Factor-Alpha; SIRT3, Sirtuin 3; FoxO3a, Forkhead box O3a; BMP-2, Bone morphogenic protein-2; ALP, Alkaline Phosphatase; COL1A1, Collagen Type I Alpha 1 Chain; OPG, Osteoprotegerin; β-actin, Beta-actin. The primer sequences used in the study. Notes: CD206, Cluster of Differentiation 206; Arg-1, Arginase-1; iNOS, Inducible Nitric Oxide Synthase; TNF-α, Tumor Necrosis Factor-Alpha; SIRT3, Sirtuin 3; FoxO3a, Forkhead box O3a; BMP-2, Bone morphogenic protein-2; ALP, Alkaline Phosphatase; COL1A1, Collagen Type I Alpha 1 Chain; OPG, Osteoprotegerin; β-actin, Beta-actin. Western blotting Total protein was isolated using Western and IP lysis buffer (Beyotime, China). Cytoplasmic and nuclear protein extracts were obtained using the NE-PER® nuclear and cytoplasmic extraction kit (Thermo Scientific, USA). The protein was resolved on 4%−20% gradient polyacrylamide gels (ACE, China) and electrotransferred to PVDF membranes (Millipore, USA). Membranes were blocked with 5% non-fat milk for 1 h at room temperature (RT), followed by incubation with primary antibodies at specified dilutions overnight at 4 °C: Cluster of Differentiation 206 (CD206; ProMab, P43398; 1:500), Arginase 1 (Arg-1; Proteintech, 66,129–1-Ig; 1:10,000), inducible nitric oxide synthase (iNOS; Proteintech, 18,985–1-AP; 1:2000), tumor necrosis factor-alpha (TNF-α; Proteintech, 60,291–1-Ig; 1:2000), SIRT3 (Cell Signaling Technology, 5493S; 1:1000), FoxO3a (Proteintech, 66,428–1-Ig; 1:2000), Sequestosome 1 (SQSTM1; Proteintech, 31,403–1-AP; 1:3000), Microtubule-associated protein 1A/1B-light chain 3B (LC3B; Abmart, T55992; 1:2000) and β-actin (Proteintech, 60,291–1-Ig; 1:10,000). After TBST washes (3 × 10 min), membranes were incubated with HRP-conjugated secondary antibodies for 1 h at RT. Protein bands were visualized using an Enhanced Chemiluminescence substrate (EpiZyme, China). Densitometric analysis was performed using Image J software, normalized to β-actin expression. Immunofluorescence RAW264.7 cells were seeded on poly-L-lysine-coated coverslips (NEST Biotechnology, China) in 6-well plates at a density of 1 × 105 cells/well. After treatment, cells were fixed with 4% paraformaldehyde for 15 min at RT. After permeabilization with 0.2% Triton X-100 for 10 min and blocking with 10% donkey serum for 30 min, slides were incubated with antibodies against SIRT3 (CST, 5493S; 1:100) and FoxO3a (Proteintech, 66,428–1-Ig; 1:100) at 4 °C overnight. Subsequently, the cells were incubated for 1 h at RT with Alexa Fluor 594-conjugated donkey anti-rabbit IgG and Alexa Fluor 488-conjugated donkey anti-mouse IgG (both from Biooss, Wuhan, China), and nuclei were counterstained with 4’,6-diamidino-2-phenylindole (DAPI). Fluorescence colocalization analysis was performed using ImageJ software, and the Pearson correlation was calculated. Reactive oxygen species assay Intracellular reactive oxygen species (ROS) were detected using the Reactive oxygen species assay kit (CA1410, Solarbio). After treatment, the old culture medium was removed, and DCFH-DA was diluted at a ratio of 1:500 in a serum-free culture medium and then added to the cells. Subsequently, the cells were incubated in a cell incubator at 37 °C for 30 min and washed three times with serum-free culture medium. The cells were observed and photographed using an inverted fluorescence microscope. Finally, the fluorescence intensity of the images was quantitatively analyzed with the help of ImageJ software. Isolation and culture of BMSCs BMSCs were isolated from 1–2-week-old male C57BL/6 J mice (4–6 g; Hunan SJA Laboratory Animal Co., Ltd, China) using a bone fragment digestion method43. Briefly, mice were deeply anesthetized via inhalation of 5% isoflurane, and after confirmation of absence of toe pinch reflex, euthanasia was performed by cervical dislocation. The bodies were then sterilized in 75% ethanol for 3–5 min. Femurs and tibiae were aseptically dissected, and adherent soft tissues were removed by gentle rubbing on sterile gauze. After excising the metaphysis, the bone marrow cavity was repeatedly flushed with DMEM until it turned white. Bones were meticulously cut into 1–3 mm3 fragments and transferred to a 50 ml centrifuge tube containing 1 mg/ml collagenase II (Gibco, USA) diluted in MSC PRO medium (Xirui Infinite, China). The fragments were digested in a shaking incubator at 37 °C and 200 rpm for 1 h. The bone fragments were plated in a 25 cm2 culture dish and cultured in MSC PRO medium, which was changed every 3 days. Cells were passaged after reaching 70–80% confluence, and the third generation of BMSCs was used for subsequent experiments. This study was approved by the Animal Ethics Committee of The Second Xiangya Hospital of Central South University (No. 20220661), with all procedures complying strictly with the ARRIVE guidelines and institutional animal care regulations. The identity of BMSCs was established by flow cytometry (CD29+/CD105+/CD11b-/CD45-), and their multilineage differentiation potential was assessed using a commercial induction kit (OriCell, China) for osteogenic, adipogenic, and chondrogenic lineages. Successful isolation of multipotent BMSCs was verified (Figure S3). Effects of MCM on BMSCs proliferation, migration, and osteogenic differentiation Scratch assay BMSCs were seeded in 6-well plates at a density of 1 × 10⁶ cells/well and cultured to 100% confluency. Cells were serum-starved for 24 h. A uniform scratch was created using a 200 μL pipette tip, and the medium was replaced with a 1:2 mixture of MCM and DMEM (supplemented with 1% FBS). Cell migration was monitored at 0, 24, and 72 h using phase-contrast microscopy, and migration rates were quantified using ImageJ software. Cell proliferation assay BMSCs were seeded in 96-well plates at a density of 5000 cells/well and cultured with a 1:2 mixture of MCM and DMEM (supplemented with 10% FBS). Cell proliferation was assessed at 1, 3, and 5 days using the CCK-8 assay (Abiowell, China). Osteogenic differentiation assay BMSCs were seeded in 24-well plates at 5 × 105 cells/well and induced with a 1:2 mixture of MCM and osteogenic induction medium. After 7 days, alkaline phosphatase (ALP) was stained using the BCIP/NBT ALP Staining Kit (C3206, Beyotime), and ALP activity was quantified using the ALP Activity assay kit (P0321, Beyotime). Extracellular matrix mineralization was assessed after 28 days by Alizarin Red S staining, followed by solubilization with 10% cetylpyridinium chloride (Sigma, USA) and absorbance measurement at 620 nm. Statistical analysis Statistical analysis was performed using GraphPad Prism 9.5.0. All data are expressed as mean ± standard deviation (SD). The normality of data distribution was confirmed using the Shapiro–Wilk test. Two-tailed Student’s t-test was used for the comparison between two groups. One-way analysis of variance (ANOVA) was used for multiple group comparisons. P < 0.05 was considered statistically significant. Supplementary Information Supplementary Information 1. Supplementary Information 2. Author contributions Conceptualization: LL, HL, QY. Investigation: LL, JR, XW, QY. Resources: QY. Formal Analysis: LL. Data curation: LL. Supervision: QY. Writing–original draft: LL. Writing–review & editing: LL. Validation: LL, JR. Visualization: LL. Funding acquisition: HL, QY. Funding This study was supported by the National Natural Science Foundation of China (No. 82360377), the Guangxi Natural Science Foundation (No. 2024GXNSFAA010047), the Natural Science Foundation of Hunan Province (No. 2023JJ60081, 2024JJ9204), and the Hunan Provincial Health Commission (No. B202308056991). Data availability The original contributions presented in the study are included in the article. Further inquiries can be directed to the corresponding authors. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Hengxing Liang, Email: Lianghengxing84@csu.edu.cn. Qianqian Yao, Email: dent_qianqianyao@csu.edu.cn. References Associated Data Supplementary Materials Supplementary Information 1. Supplementary Information 2. Data Availability Statement The original contributions presented in the study are included in the article. Further inquiries can be directed to the corresponding authors.